Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Remdesivir Approved by FDA Experimental Antiviral Jan/18/2023 75 6
BNT162b2 Approved by FDA Experimental Vaccine Jul/11/2022 66 0
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Oct/29/2021 95 23
Favipiravir Potential treatment - clinical evidence Used to treat other disease Antiviral Sep/24/2021 27 7
Lopinavir Recommended by China's NHC Guidelines Used to treat other disease Antiviral Apr/22/2021 26 15
NVX-CoV2373 Potential treatment - clinical evidence Experimental Vaccine Apr/07/2021 6 0
Arbidol Recommended by China's NHC Guidelines Used to treat other disease Antiviral Apr/03/2021 14 3
Nitazoxanide Potential treatment - clinical evidence Used to treat other disease Antiviral Mar/16/2021 7 1
Amodiaquine Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/12/2021 6 0
Emetine Potential treatment - pre-clinical evidence Experimental Antiviral Mar/10/2021 7 0
Excel (.xslx) CSV (.csv)